SCHEMBL17563256

SCHEMBL17563256

CCn1cnc2cc(C)c(F)c(F)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ADORA2A P29274 1/20 0.37
KCNH2 Q12809 1/20 0.36
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
GGPS1 O95749 1/20 0.34
FDPS P14324 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
FABP6 P51161 1/20 0.33
HTT P42858 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19619633 0.81 ADORA2A (0.36) LMNAMEN1KMT2AADORA2ADPP4
SCHEMBL24463334 0.81 ADORA2A (0.36) LMNAMEN1KMT2AADORA2ADPP4
SCHEMBL26790826 0.79 ADORA2A (0.34) MEN1KMT2AADORA2ADPP4DPP8
SCHEMBL17694873 0.79 ADORA2A (0.34) POLBMEN1KMT2AADORA2ADPP4
SCHEMBL17563255 0.77 DPP4 (0.36) LMNAPOLBMEN1KMT2AADORA2A
SCHEMBL24463137 0.76 DPP4 (0.39) LMNAPOLBMEN1KMT2AADORA2A
SCHEMBL30490152 0.76 DPP4 (0.39) LMNAPOLBMEN1KMT2AADORA2A
SCHEMBL26790835 0.74 ADORA2A (0.31) ADORA2ADPP4DPP8
SCHEMBL17563258 0.72 LMNA (0.53) LMNAPOLBMEN1KMT2AKCNH2
SCHEMBL17563262 0.72 ABL1 (0.38) POLBKMT2AADORA2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9822119-B2 Inhibitors of lysine specific demethylase-1 CELGENE QUANTICEL RESEARCH, INC. (US) 2017-11-21 US disclosed
US-20160108046-A1 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 CELGENE QUANTICEL RESEARCH, INC. 2016-04-21 US disclosed
WO-2016037005-A1 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 Quanticel Pharmaceuticals, Inc. (US) 2016-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108046-A1 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 KDM1B, KDM1A, KDM3A LMNA 2879/4885POLB 2723/4885MEN1 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.